Sentire

Medtronic to Invest $700M in Cornerstone Robotics for Sentire Rights

Hong Kong – September 08, 2026 -- Medtronic (NYSE: MDT) will invest approximately $700 million in Hong Kong-based Cornerstone Robotics as part of a strategic alliance granting the U.S. medtech giant distribution rights to the Sentire surgical robotic system in select markets outside the United States where the device is approved.

Medtronic gains distribution rights to Sentire outside the U.S.

The agreement covers markets where Sentire has already secured regulatory clearance, positioning the system alongside Medtronic's existing Hugo robotic surgical platform. Sentire received approval from China's National Medical Products Administration in 2024, followed by CE marking in the European Union and clearance from Singapore's Health Sciences Authority in May 2026 for general, gynecological, thoracic and urological minimally invasive procedures.

Medtronic Invests $700M in Cornerstone Robotics for Sentire Rights

Hong Kong – September 08, 2026 -- Medtronic (NYSE: MDT) will make a strategic investment of approximately $700 million in Hong Kong-based Cornerstone Robotics, securing distribution rights for the Sentire surgical system in select markets outside the United States where the device is already cleared.

Medtronic secures rights to Sentire outside the US market

The agreement gives Medtronic distribution rights to Cornerstone Robotics' Sentire surgical system in ex-US markets where regulatory approval has already been granted. Matt Anderson, Senior Vice President and President of Medtronic's surgical solutions division, said the deal expands robotics choice for patients and positions Sentire as a complement to Medtronic's existing Hugo platform.